1. Home
  2. JKS vs PCRX Comparison

JKS vs PCRX Comparison

Compare JKS & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JinkoSolar Holding Company Limited (each representing 4)

JKS

JinkoSolar Holding Company Limited (each representing 4)

HOLD

Current Price

$8.39

Market Cap

1.0B

Sector

Technology

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

BUY

Current Price

$36.38

Market Cap

1.0B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
JKS
PCRX
Founded
2006
2006
Country
China
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2010
2010

Fundamental Metrics

Financial Performance
Metric
JKS
PCRX
Price
$8.39
$36.38
Analyst Decision
Hold
Hold
Analyst Count
7
9
Target Price
$20.02
★ $33.57
AVG Volume (30 Days)
652.1K
★ 2.2M
Earning Date
10-30-2026
11-05-2026
Dividend Yield
★ 18.43%
N/A
EPS Growth
N/A
★ 107.44
EPS
N/A
★ 0.19
Revenue
N/A
★ $541,533,000.00
Revenue This Year
N/A
$3.84
Revenue Next Year
$38.19
$4.73
P/E Ratio
★ N/A
$191.21
Revenue Growth
N/A
★ 26.04
52 Week Low
$7.83
$18.80
52 Week High
$31.88
$36.67

Technical Indicators

Market Signals
Indicator
JKS
PCRX
Relative Strength Index (RSI) 31.47 83.59
Support Level N/A $22.13
Resistance Level $17.28 $36.67
Average True Range (ATR) 0.38 0.21
MACD 0.13 0.25
Stochastic Oscillator 36.39 97.60

Price Performance

Historical Comparison
JKS
PCRX

About JKS JinkoSolar Holding Company Limited (each representing 4)

JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), the Americas, Europe, Asia Pacific, and the Rest of the world.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: